Foreign Body Granuloma Originating From the Lateral Process of Malleus: A Case Series of 19 Children.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 Aug 2023
01 Aug 2023
Historique:
medline:
17
7
2023
pubmed:
14
6
2023
entrez:
13
6
2023
Statut:
ppublish
Résumé
A special presentation of foreign body granuloma originating from the lateral process of the malleus (FBGLP) was noted in the absence of a history of foreign body entry into the external auditory canal (EAC). This study reported the clinical features, pathology, and prognosis of patients with FBGLP. Retrospective study. Shandong Provincial ENT Hospital. Nineteen pediatric patients (age, 1-10 yr) with FBGLP. Clinical data were collected from January 2018 to January 2022. Clinicopathologic characteristics of the patients were analyzed. All patients had an acute course, and were within 3 months of ineffective medical treatment. The most common symptoms were suppurative (57.9%) and hemorrhagic (42.1%) otorrhea. FBGLP imaging examinations demonstrated a soft mass blocking the EAC without bone destruction and occasionally concomitant effusion in the middle ear. The most common pathologic findings were foreign body granuloma (94.7%,18/19), granulation tissue (73.7%, 14/19), keratotic precipitate (73.7%, 14/19), calcium deposition (63.2%, 12/19), hair shafts (47.4%, 9/19), cholesterol crystals (5, 26.3%), and hemosiderin (15.8%, 3/19). Foreign body granuloma and granulation tissue showed higher expression levels of CD68 and cleaved caspase-3 than did the normal tympanic mucosa, whereas Ki-67 levels were similarly low in all tissues. The patients were followed up for 3 months to 4 years without recurrence. FBGLP is caused by endogenous foreign particles in the ear. We recommend the trans-external auditory meatus approach for FBGLP surgical excision, as this shows promising outcomes.
Identifiants
pubmed: 37311639
doi: 10.1097/MAO.0000000000003918
pii: 00129492-990000000-00309
pmc: PMC10348615
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
702-708Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.
Références
Annu Rev Immunol. 2018 Apr 26;36:639-665
pubmed: 29400999
Braz J Otorhinolaryngol. 2008 Jan-Feb;74(1):7-15
pubmed: 18392495
Nat Rev Immunol. 2012 Apr 20;12(5):352-66
pubmed: 22517424
J Otol. 2019 Mar;14(1):26-29
pubmed: 30936899
J Otolaryngol. 1976 Jun;5(3):221-6
pubmed: 778398
Dermatol Clin. 2015 Jul;33(3):497-523
pubmed: 26143429
Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110354
pubmed: 33152957
Pediatrics. 2004 Apr;113(4):e371-3
pubmed: 15060270
Am J Ophthalmol. 2011 Jan;151(1):7-10.e1
pubmed: 21163373